1. Endothelial cells in the eyes of an immunologist

   • M. Rita Young

   Review 18 August 2012 Pages: 1609 - 1616

   

2. In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model

   • Alessa Pardo
   • Michael Stöcker
   • Stefan Barth

   Original article 19 February 2012 Pages: 1617 - 1626

   

3. TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines

   • Kimberly R. Jordan
   • Jonathan D. Buhrman
   • Jill E. Slansky

   Original article Open access 21 February 2012 Pages: 1627 - 1638

   

4. Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation

   • Janina Rahlff
   • Maria Trusch
   • Mascha Binder

   Original article 21 February 2012 Pages: 1639 - 1651

   

5. Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneously

   • Jing Zhang
   • Jinpu Yu
   • Xiubao Ren

   Original article 26 February 2012 Pages: 1653 - 1661

   

6. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer

   • Sumiya Ishigami
   • Takaaki Arigami
   • Shoji Natsugoe

   Original article 29 February 2012 Pages: 1663 - 1669

   

7. Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2_180–188-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2_180–188 peptides

   • Jeong-Im Sin
   • Jae-Bok Park
   • Esteban Celis

   Original article 02 March 2012 Pages: 1671 - 1682

   

8. Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects

   • Alexander L. Rakhmilevich
   • Mark J. Baldeshwiler
   • Paul M. Sondel

   Original article 06 March 2012 Pages: 1683 - 1697

   

9. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK)

   • Jingling Liu
   • Wenna Chen
   • Fengping Shan

   Original article 06 March 2012 Pages: 1699 - 1711

   

10. Inhibition of stromal CXCR4 impairs development of lung metastases

    • Crescenzo D’Alterio
    • Antonio Barbieri
    • Stefania Scala

    Original article Open access 08 March 2012 Pages: 1713 - 1720

    

11. Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity

    • Timothy S. Fisher
    • Cris Kamperschroer
    • Leslie L. Sharp

    Original article 11 March 2012 Pages: 1721 - 1733

    

12. Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells

    • Yan Zhou
    • Jing He
    • Jin-liang Yang

    Original Article 11 March 2012 Pages: 1735 - 1743

    

13. Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity

    • Shuli Zhao
    • Huijuan Wang
    • Yayi Hou

    Original article 14 March 2012 Pages: 1745 - 1753

    

14. Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses

    • Wenna Chen
    • Jinling Liu
    • Fengping Shan

    Original article 15 March 2012 Pages: 1755 - 1768

    

15. Hodgkin’s lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses

    • Carolin Winkler
    • Daniel Sebastian Steingrube
    • Martin Sebastian Staege

    Original article 15 March 2012 Pages: 1769 - 1779

    

16. Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort study

    • Kazuro Iwai
    • Kenzo Soejima
    • Shigenori Goto

    Original article Open access 16 March 2012 Pages: 1781 - 1790

    

17. Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

    • Eva Ellebaek
    • Lotte Engell-Noerregaard
    • Inge Marie Svane

    Original article 20 March 2012 Pages: 1791 - 1804

    

18. CA215 and GnRH receptor as targets for cancer therapy

    • Gregory Lee
    • Anthony P. Cheung
    • Jiang Gu

    Original article 21 March 2012 Pages: 1805 - 1817

    

19. Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma

    • Corey M. Munger
    • Ganapati V. Hegde
    • Shantaram S. Joshi

    Original article 23 March 2012 Pages: 1819 - 1832

    

20. CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy

    • Sivan Sapoznik
    • Rona Ortenberg
    • Gal Markel

    Original article 24 March 2012 Pages: 1833 - 1847

    

21. Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer

    • Hui Liu
    • Tiantuo Zhang
    • Jinghui Hou

    Original article 29 March 2012 Pages: 1849 - 1856

    

22. DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model

    • Haihong Zhang
    • Yuqian Wang
    • Wei Kong

    Original article 17 June 2012 Pages: 1857 - 1867

    

23. T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16

    • Lisa M. Pörtner
    • Kathrin Schönberg
    • Markus Uhrberg

    Short communication 14 September 2012 Pages: 1869 - 1875

    

24. Second International Symposium on Cancer Biology (ISCB), November 14–16, 2011, at the National Institute of Immunology, New Delhi, India

    • Anil Suri
    • Shikha Saini
    • Namita Gupta

    Meeting report 18 July 2012 Pages: 1877 - 1882

25. In memory of Professor Robert W. Baldwin: Editor-in-Chief of Cancer Immunology, Immunotherapy 1976–2003

    Obituary 14 September 2012 Pages: 1883 - 1883